Found: 4
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018
Kushlinskii N.E., Chernomaz I.S., Gershtein E.S., Boulytcheva I.V., Aliev M.D., Soloviev Yu.N.
Introduction. The search of molecular markers for early diagnostics, prognosis, and identification of new objects for molecular-targeted therapy of primary bone tumors remains one of the most important tasks despite the significant achievements in the treatmen…
Research article2014
Kushlinskii N.E., Babkina I.V., Kuznetsov I.N., Korotkova E.A., Ten E.A., Bulycheva I.V., Solovev Yu.N., Aliev M.D.
Introduction. Matrix metalloproteinase (MMP) – a family of extracellular zinc-containing proteases. There are currently 25 known MMP. Increased activity of MMP observed in some physiological processes – during the follicular phase of the menstrual cycle and du…
Research article2013
Gershtein E.S., Korotkova E.A., Prorokov V.V., Kushlinskii N.E.
Associations between matrix metalloproteinase (MMP) 2, 7, 9, tissue MMP inhibitor TIMP-1 and plasminogen activation system components (uPA, tPA and PAI-1) plasma and/or tumor levels in colorectal cancer (CRC) patients were evaluated in order to reveal their po…
Research article2013
Gershtein E.S., Kushlinsky D.N., Adamyan L.V., Tereshkina I.V., Laktionov K.P.
Publications devoted to the role of various representatives of matrix metalloproteinases (MMPs) family and their tissue inhibitors in ovarian cancer in differential diagnostics, prognosis and in the development of new treatment modalities are critically analyz…